NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 323 filers reported holding NATERA INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,646 | +413.4% | 105 | +250.0% | 0.00% | – |
| Q2 2023 | $905 | +417.1% | 30 | +100.0% | 0.00% | – |
| Q1 2023 | $175 | +5733.3% | 15 | -87.7% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 122 | +67.1% | 0.00% | – |
| Q3 2022 | $3,000 | +50.0% | 73 | +58.7% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 46 | -28.1% | 0.00% | – |
| Q1 2022 | $3,000 | – | 64 | – | 0.00% | – |
| Q2 2021 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q1 2021 | $0 | – | 3 | -25.0% | 0.00% | – |
| Q4 2020 | $0 | – | 4 | -50.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 8 | -96.0% | 0.00% | – |
| Q2 2018 | $4,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,104,581 | $48,403,000 | 19.54% |
| Kynam Capital Management, LP | 2,018,360 | $88,445,000 | 18.64% |
| Foresite Capital Management III, LLC | 159,160 | $6,974,000 | 18.41% |
| Sofinnova Investments, Inc. | 3,102,960 | $135,972,000 | 7.91% |
| Eagle Health Investments LP | 595,994 | $26,116,000 | 5.99% |
| Eversept Partners, LP | 1,425,602 | $62,469,880 | 5.41% |
| Lagoda Investment Management, L.P. | 159,220 | $6,977,000 | 4.96% |
| Hudson Executive Capital LP | 588,886 | $25,805,000 | 3.70% |
| Parian Global Management LP | 24,000 | $1,052,000 | 3.42% |
| BRANDYWINE MANAGERS, LLC | 21,534 | $944,000 | 3.10% |